BIOMARKER:

STAG2 mutation

Entrez ID:

Related biomarkers:

‹

›

STAG2 mutation STAG2 mutation	Acute Myelogenous Leukemia AML	talazoparib Sensitive: C2 – Inclusion Criteria
STAG2 mutation STAG2 mutation	Acute Myelogenous Leukemia AML	cytarabine/daunorubicin liposomal formulation Sensitive: C3 – Early Trials
STAG2 mutation STAG2 mutation	Acute Myelogenous Leukemia AML	LY3009120 Resistant: C3 – Early Trials
STAG2 mutation STAG2 mutation	Colorectal Cancer CRC	sintilimab + fruquintinib Resistant: C3 – Early Trials
STAG2 mutation STAG2 mutation	Glioblastoma GBM	olaparib Sensitive: D – Preclinical

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

Associations